XML 105 R79.htm IDEA: XBRL DOCUMENT v3.24.0.1
Segment and Geographic Data (Sales And Other Financial Information By Business Segment) (Details)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2023
USD ($)
Sep. 30, 2023
USD ($)
Jun. 30, 2023
USD ($)
Mar. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Sep. 30, 2022
USD ($)
Jun. 30, 2022
USD ($)
Mar. 31, 2022
USD ($)
Dec. 31, 2023
USD ($)
segment
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Segment Reporting [Abstract]                      
Number of reportable segments | segment                 2    
Segment Reporting Information [Line Items]                      
Number of reportable segments | segment                 2    
Net sales $ 5,815,000 $ 4,909,000 $ 4,996,000 $ 4,778,000 $ 5,202,000 $ 4,479,000 $ 4,493,000 $ 4,275,000 $ 20,498,000 $ 18,449,000 $ 17,108,000
Depreciation and amortization                 1,341,000 1,278,000 1,272,000
Segment net earnings (loss)                 3,888,000 2,841,000 2,584,000
Amortization of intangible assets                 (635,000) (627,000) (619,000)
Goodwill impairment                 0 (216,000) 0
Net earnings $ 1,143,000 $ 692,000 $ 738,000 $ 592,000 $ 563,000 $ 816,000 $ 656,000 $ 323,000 3,165,000 2,358,000 1,994,000
MedSurg and Neurotechnology                      
Segment Reporting Information [Line Items]                      
Net sales                 11,836,000 10,611,000 9,538,000
Goodwill impairment                   0  
Orthopaedics and Spine                      
Segment Reporting Information [Line Items]                      
Net sales                 8,662,000 7,838,000 7,570,000
Goodwill impairment                   (216,000)  
Operating Segments                      
Segment Reporting Information [Line Items]                      
Depreciation and amortization                 1,201,000 1,154,000 1,147,000
Segment operating income                 5,735,000 5,033,000 4,987,000
Operating Segments | MedSurg and Neurotechnology                      
Segment Reporting Information [Line Items]                      
Net sales                 11,836,000 10,611,000 9,538,000
Depreciation and amortization                 564,000 540,000 518,000
Segment net earnings (loss)                 3,336,000 2,737,000 2,807,000
Operating Segments | Orthopaedics and Spine                      
Segment Reporting Information [Line Items]                      
Net sales                 8,662,000 7,838,000 7,570,000
Depreciation and amortization                 637,000 614,000 629,000
Segment net earnings (loss)                 2,399,000 2,296,000 2,180,000
Corporate and Other                      
Segment Reporting Information [Line Items]                      
Depreciation and amortization                 140,000 124,000 125,000
Segment operating income                 (780,000) (649,000) (605,000)
Segment Reconciling Items                      
Segment Reporting Information [Line Items]                      
Acquisition and integration-related charges                 (20,000) (150,000) (585,000)
Structural optimization and other special charges                 (206,000) (349,000) (386,000)
Medical device regulations                 (96,000) (140,000) (107,000)
Recall-related matters                 (18,000) 15,000 (103,000)
Regulatory and legal matters                 (92,000) (76,000) 2,000
Net earnings                 $ 3,888,000 $ 2,841,000 $ 2,584,000